Siponimod
NDC Package 50742-326-07

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Siponimod is a . Marketed by Ingenus Pharmaceuticals, Llc, this product is identified by NDC 50742-326 and is authorized under FDA application ANDA218444.

Identification & Billing

NDC Package Code
50742-326-07
Package Description
1 BLISTER PACK in 1 BLISTER PACK / 7 TABLET, FILM COATED in 1 BLISTER PACK
Product Code
11-Digit Billing Format
50742032607

Clinical Specifications

Proprietary Name
Siponimod
Dosage Form
-

Regulatory & Marketing

Labeler Name
Ingenus Pharmaceuticals, Llc
FDA Application #
ANDA218444
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
04-22-2025
End Marketing Date
04-22-2025
Listing Expiration
04-22-2025
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (50742-326). Click a package code to view its specific billing and regulatory data.

1 BLISTER PACK in 1 BLISTER PACK / 12 TABLET, FILM COATED in 1 BLISTER PACK
1 BOTTLE in 1 BOTTLE / 28 TABLET, FILM COATED in 1 BOTTLE

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 50742-326-07 identifies a specific commercial package of 1 blister pack in 1 blister pack / 7 tablet, film coated in 1 blister pack of Siponimod, labeled by Ingenus Pharmaceuticals, Llc. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Ingenus Pharmaceuticals, Llc on April 22, 2025. The current certification is valid through April 22, 2025.

How is this Ingenus Pharmaceuticals, Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 50742032607. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
50742-326-07
11-Digit CMS (5-4-2)
50742-0326-07

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.